Loading…
Absci Corporation is projected to rise to $15.57 by 2027, a +47% move from its current price of $10.60. ABSI is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $10.02 | $10.61 | $11.23 | +0.09% |
| Jul 14 | $9.79 | $10.62 | $11.52 | +0.18% |
| Jul 15 | $9.63 | $10.63 | $11.74 | +0.27% |
| Jul 16 | $9.49 | $10.64 | $11.93 | +0.36% |
| Jul 17 | $9.37 | $10.65 | $12.10 | +0.46% |
| Jul 18 | $9.26 | $10.66 | $12.26 | +0.55% |
| Jul 19 | $9.17 | $10.67 | $12.41 | +0.64% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $9.17 | $10.67 | $12.41 | +0.64% |
| Week 2 | $8.67 | $10.74 | $13.30 | +1.28% |
| Week 3 | $8.31 | $10.80 | $14.05 | +1.93% |
| Week 4 | $8.03 | $10.87 | $14.72 | +2.58% |
| Week 5 | $7.80 | $10.94 | $15.35 | +3.23% |
| Week 6 | $7.60 | $11.01 | $15.96 | +3.89% |
| Week 7 | $7.42 | $11.08 | $16.55 | +4.55% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Absci Corporation is a clinical-stage biopharmaceutical company that develops antibody therapeutics in the United States. It is categorized in Healthcare and focuses on multiple preclinical and clinical programs.
Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. The company has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities.
The company was founded in 2011 and is headquartered in Vancouver, Washington.
Absci Corporation (ABSI) is trading with a current price of $10.89 and has a market capitalization of $1.84B, ranking 2095 by market cap. The stock’s price outlook shows a mix of near-term neutral momentum and longer-term bullish potential according to the provided forecast data.
In 2026, the forecast shows an average price of $10.89 with a neutral sentiment and 0% ROI, suggesting stability around the current price. The subsequent years show rising averages and bullish sentiment, with 2027 averaging $15.87 and 2028 averaging $15.53, moving higher through 2030 ($17.19) and 2035 ($33.59).
Beyond the mid-2020s, the forecast projects substantial upside, with 2040 averaging $60.27 and 2050 averaging $88.63, accompanied by very large ROI estimates to reflect long-term growth potential.
A major floor 78.3% below — a decisive break under it would weaken the trend.
The nearest floor, 44.0% below — buyers have tended to step in here.
The nearest ceiling, 9.6% above — a clean break opens room to run.
A major ceiling 42.1% above — clearing it would confirm fresh momentum.
Key ABSI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ABSI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $11.21 | Sell | $11.06 | Sell |
| MA 10 | $11.26 | Sell | $10.79 | Sell |
| MA 20 | $9.54 | Buy | $9.80 | Buy |
| MA 50 | $7.23 | Buy | $7.75 | Buy |
| MA 100 | $5.12 | Buy | $6.12 | Buy |
| MA 200 | $4.27 | Buy | $4.89 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.20 | Neutral |
| Stoch RSI (14) | 13.31 | Buy |
| CCI (20) | 38.36 | Neutral |
| Williams %R (14) | -24.23 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | 43.05 | Buy |
| Bollinger %B (20,2) | 0.64 | Neutral |
| Stochastic %K (14) | 75.77 | Neutral |
| TRIX (15) | 2.66 | Buy |
| Awesome (5,34) | 3.07 | Buy |
| Ultimate (7,14,28) | 46.72 | Neutral |
| Momentum (10) | 0.39 | Buy |
| Aroon Osc (25) | 80.00 | Buy |
| Hull MA (9) | 11.08 | Sell |
| ADX (14) | 35.62 | Buy |
| ATR (14) | 0.48 | Info |
The 30-day technical picture is bullish in sentiment. RSI(14) sits at 70, supporting a bullish tilt near overbought levels. The 50-day simple moving average is $5.92 and the 200-day simple moving average is $3.88, indicating upside momentum aligning with the bullish note.
Key support is listed at $4.63 and resistance at $10.89, which aligns with the current price level. The stock’s 30-day price range spans from $6.88 to $17.22, illustrating a broad trading band over the last month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.30 | $10.60 | $15.33 | 0% | Neutral | |
| $11.29 | $15.57 | $23.20 | +47% | Bullish | |
| $10.95 | $16.03 | $25.46 | +51% | Bullish | |
| $11.53 | $17.80 | $29.67 | +68% | Bullish | |
| $11.04 | $17.86 | $30.99 | +68% | Bullish | |
| $10.66 | $18.02 | $32.37 | +70% | Bullish | |
| $15.63 | $27.57 | $51.06 | +160% | Bullish | |
| $18.94 | $34.78 | $66.22 | +228% | Bullish | |
| $18.77 | $35.86 | $70.00 | +238% | Bullish | |
| $17.83 | $35.40 | $70.71 | +234% | Bullish | |
| $30.95 | $68.79 | $151.00 | +549% | Bullish | |
| $44.91 | $99.80 | $229.54 | +842% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.30 | $10.60 | $13.21 | +0.00% |
| August 2026 | $8.93 | $10.82 | $13.65 | +2.05% |
| September 2026 | $9.37 | $11.52 | $14.83 | +6.45% |
| October 2026 | $9.76 | $12.14 | $15.91 | +5.41% |
| November 2026 | $9.30 | $11.68 | $15.53 | -3.74% |
| December 2026 | $8.97 | $11.38 | $15.33 | -2.59% |
Click any year to see its month-by-month ABSI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ABSI is projected to trade between $2.30 and $15.33, averaging $10.60 — a potential gain of 0% from today's $10.60. Price action looks broadly range-bound.
Absci Corporation's 2027 outlook centres on $15.57, within a $11.29 to $23.20 range. That is up +47% on the projected 2026 average. That marks a +47% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, ABSI could reach as high as $25.46, with a base case around $16.03 and support toward $10.95 — roughly +51% from $10.60. Momentum favours further upside here.
Expect ABSI to range from $11.53 to $29.67 through 2029. The $17.80 average target implies a +68% move from current prices. That is up +11% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The ABSI price prediction for 2030 points to an average of $17.86 (low $11.04, high $30.99) — a potential gain of +68% on today's $10.60. Momentum favours further upside here.
In 2031, ABSI is projected to trade between $10.66 and $32.37, averaging $18.02 — a potential gain of +70% from today's $10.60. That is up +1% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Absci Corporation's 2032 outlook centres on $27.57, within a $15.63 to $51.06 range. That is up +53% on the projected 2031 average. That marks a +160% change versus current levels. Momentum favours further upside here.
By 2033, ABSI could reach as high as $66.22, with a base case around $34.78 and support toward $18.94 — roughly +228% from $10.60. Buyers look set to stay in control over this stretch.
Expect ABSI to range from $18.77 to $70.00 through 2034. The $35.86 average target implies a +238% move from current prices. That is up +3% on the projected 2033 average. Momentum favours further upside here.
The ABSI price prediction for 2035 points to an average of $35.40 (low $17.83, high $70.71) — a potential gain of +234% on today's $10.60. Buyers look set to stay in control over this stretch.
In 2040, ABSI is projected to trade between $30.95 and $151.00, averaging $68.79 — a potential gain of +549% from today's $10.60. That is up +94% on the projected 2035 average. Momentum favours further upside here.
Absci Corporation's 2050 outlook centres on $99.80, within a $44.91 to $229.54 range. That is up +45% on the projected 2040 average. That marks a +842% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in ABSI today (≈ 94.339623 ABSI) could be worth
$9,415.23
+$8,415.23 (+842%) by 2050 · US Dollar
Based on the average projected ABSI price of $99.8 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ABSIwould be worth at today's price.
$1,000 invested in ABSI on Jul 10, 2025 (≈ 366.300364 ABSI) would be worth
$3,882.78
+$2,882.78 (+288.3%) today · 3.88× · US Dollar
Based on a ABSI entry price of $2.73 vs. today's $10.6.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $11.62 | $912.22 | -8.8% |
| 1 month ago | $6.38 | $1,661.44 | +66.1% |
| 3 months ago | $2.98 | $3,557.05 | +255.7% |
| 6 months ago | $3.4 | $3,117.65 | +211.8% |
| 1 year ago | $2.73 | $3,882.78 | +288.3% |
| All time (5.0y) ago | $21.59 | $490.97 | -50.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ABSI forecast.
Our base-case forecast reaches $21.00 around 2032.
Implied market cap at $21.00: $3.56B
The multi-year forecast shows a bullish trajectory with expanding price expectations into the late 2020s and well into the 2040s and 2050s. For 2026, the min is $2.30, the avg is $10.89, and the max is $16.04, with an ROI of 0 and a Neutral sentiment. In 2027 the avg rises to $15.87 with a 45.8% ROI and a Bullish sentiment, followed by 2028 at $15.53 (42.6% ROI) and 2029 at $17.51 (60.8% ROI).
The 2030 and 2031 forecasts show continued upside with 2030 avg $17.19 (57.9% ROI) and 2031 avg $16.63 (52.8% ROI). 2032 through 2035 exhibit stronger growth, with 2032 avg $27.04 (148.3% ROI), 2033 avg $32.50 (198.4% ROI), 2034 avg $31.74 (191.4% ROI), and 2035 avg $33.59 (208.4% ROI).
Beyond 2035, the forecast shows significant upside: 2040 avg $60.27 (453.5% ROI) and 2050 avg $88.63 (713.9% ROI), both with Bullish sentiment. These figures illustrate a long-run path of substantial appreciation according to the projected data, though they are estimates and not guarantees.
Tap a question to reveal the answer.
The forecast shows min $2.30, avg $10.89, max $16.04, ROI 0, sentiment Neutral.
The forecast shows min $11.49, avg $15.87, max $23.73, ROI 45.8, sentiment Bullish.
Yes. The 2032 forecast lists a max of $50.14, and 2033 lists a max of $61.94, indicating the potential to exceed $50 within the forecast horizon.
2040 is forecast to be min $27.12, avg $60.27, max $132.40, ROI 453.5, sentiment Bullish. 2050 is forecast to be min $39.89, avg $88.63, max $203.86, ROI 713.9, sentiment Bullish.
Current price is $10.89; market cap is $1.84B; rank 2095.
Absci Corporation Community Discussion
0Share your Absci Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.